showed that the treatment of CD19 B-lineage leukemia cell lines with exosomes expressing CD19 Chimeric Antigen Receptor (CAR) induced cytotoxicity and elevated pro-apoptotic genes in CD19-positive leukemia B-cells without inducing cell death in CD19-negative cells (203). The gene discussed is CD19; the disease is leukemia.